CONMED
CNMD
236 hedge funds and large institutions have $1.21B invested in CONMED in 2026 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 98 increasing their positions, 73 reducing their positions, and 57 closing their positions.
175% more call options, than puts
Call options by funds: $3.78M | Put options by funds: $1.38M
34% more repeat investments, than reductions
Existing positions increased: 98 | Existing positions reduced: 73
0.89% more ownership
Funds ownership: 109.73% → 110.62% (+0.89%)
11% less funds holding
Funds holding: 265 → 236 (-29)
13% less capital invested
Capital invested by funds: $1.38B → $1.21B (-$174M)
42% less first-time investments, than exits
New positions opened: 33 | Existing positions closed: 57
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Investments
New York
|
+$20.8M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$13.7M |
| 3 |
Hotchkis & Wiley Capital Management
Los Angeles,
California
|
+$12.9M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$12M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
+$11.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$23.3M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$16M |
| 3 |
SAM
Silvercrest Asset Management
New York
|
-$8.88M |
| 4 |
Jane Street
New York
|
-$7.32M |
| 5 |
Morgan Stanley
New York
|
-$6.64M |
CNMD Hedge Fund Activity: Q1 2026 in Review
236 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in CONMED (CNMD) for Q1 2026, worth a combined $1.21B — down 13% from $1.38B a quarter earlier.
Sellers outnumbered buyers: 57 funds closed out of CNMD and 33 opened new positions — a net loss of 24 holders — while 73 trimmed existing stakes and 98 added.
The largest buyer was Two Sigma Investments, adding an estimated $20.8M. The largest seller was Wasatch Advisors, exiting entirely with an estimated $23.3M sold.
- 236 institutional investors held CONMED (CNMD) as of Q1 2026, down from 265 in Q4 2025.
- Funds reported $1.21B of CONMED stock for Q1 2026, down 13% quarter-over-quarter.
- 33 funds opened new CONMED positions in Q1 2026 and 57 closed out, a net change of -24 holders.
- The largest CONMED buyer in Q1 2026 was Two Sigma Investments, an estimated $20.8M added.
- The largest CONMED seller in Q1 2026 was Wasatch Advisors, an estimated $23.3M sold.
Based on aggregated 13F filings for Q1 2026.